Arner E, Westermark PO, Spalding KL, et al
S3896 The risks of the new weight loss medications
Your body is also adjusting to a new hormonal signal, and this metabolic shift requires adaptation time
CrossRef Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy Andrew J
doi: 10.1530/JOE-13-0221 24 SeinoYFukushimaMYabeD
(2015) www.sciencedaily.com From the article: Previous studies, he adds, have shown that taking testosterone at the wrong time particularly by men with symptoms of active cancer progression who have not yet received testosterone-blocking therapy can make the disease worse